- Acousia Therapeutics GmbH
Tübingen, Germany (OTE) - Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced the completion of patient enrollment in...
- 08.01.2026, 09:03:02
- /
- OTE0001
- Acousia Therapeutics GmbH
Tübingen, Germany (OTE) - Acousia Therapeutics GmbH announced that it has successfully enrolled 50% of patients in its ongoing Phase 2 clinical trial, the PROHEAR Study , evaluating ACOU085 (INN: bimokalner) for...
- 29.04.2025, 09:02:47
- /
- OTE0001
- Acousia Therapeutics GmbH
Tübingen, Germany (OTE) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR...
- 12.08.2024, 09:01:18
- /
- OTE0001
- Acousia Therapeutics GmbH
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, just announced the randomization of the first...
- 15.02.2024, 09:01:42
- /
- OTE0001
- Acousia Therapeutics GmbH
Tübingen (ots) - Acousia Therapeutics GmbH, a clinical-stage biotech company developing drug candidates against acute and chronic forms of hearing loss, proudly announces Esperante Ventures as the latest addition...
- 09.01.2024, 10:00:50
- /
- OTE0001
So erreichen Sie uns
APA-Comm GmbH
Laimgrubengasse 10
1060 Wien, Österreich
PR-Desk Support
Tel. +43 1 36060-5310
APA-Salesdesk
Tel. +43 1 36060-1234
